
Dr. Salvador Sarró
Psychiatrist · Licence No. 27.765 (COMB)
Dr. Salvador Sarró Maluquer is a psychiatrist with a PhD in Psychiatry from the Autonomous University of Barcelona (UAB) and director of Institut Sarró in Barcelona. He combines clinical practice with research and university teaching, and offers a frank, direct and pragmatic approach to the assessment, strategic planning and follow-up of each patient's individualised treatment.
How they can help you
Mood and Anxiety Disorders
Depression, generalised anxiety, panic attacks and phobias. Bipolar disorder and cyclothymia.
ADHD and Obsessive Spectrum
Obsessive-compulsive disorder (OCD), intrusive thoughts, impulse phobias (harm OCD) and ADHD.
Complex Physical Symptoms
Assessment of symptoms that often lead to a long medical journey and many tests (tinnitus, dizziness or unsteadiness, non-specific pain or functional digestive disorders).
Anxiety disorders
Generalised anxiety (GAD), agoraphobia, specific phobias. Panic attacks.
Second Medical Opinions
Assessment of cases with poor response or progress on previous treatments, and review of medication and its side effects.
Professional background
He inherited from his father, who already practiced psychiatry in Barcelona, the vocation and passion for this specialty: alleviating the suffering associated with these disorders and experiencing the satisfaction of seeing their favorable evolution.
He knows firsthand the impact of these pathologies, both on the patient’s life and on that of those around him. Although they are often not life-threatening illnesses, they do involve a high degree of dysfunction and discomfort. Contrary to common perception, psychiatry is one of the medical specialties with the highest return and is very appreciated: with an appropriate therapeutic approach, most patients improve significantly and recover their well-being and quality of life, despite having suffered from them for years.
He has worked in different hospital units at the Benito Menni Hospital and as founder and head of the Psychiatry Service at the General Hospital of Granollers. In recent years, he has dedicated his professional activity to research, as a researcher and head of administration at the FIDMAG Research Foundation and in the CIBERSAM ISCIII research group.
He has extensive experience in high-precision pharmacological treatment and in the management of its side effects, an approach that he complements with psychotherapy when the case requires it.
Education and training
1990Degree in Medicine and Surgery (MD) — Universitat de Barcelona (UB)
1995Specialist in Psychiatry (MIR) — Ministerio de Sanidad
2018PhD in Psychiatry (cum laude) — Universitat Autònoma de Barcelona (UAB)
Professional experience
PresentDirector Institut Sarró, Barcelona
2011 – presentSenior researcher FIDMAG Hermanas Hospitalarias Research Foundation (CIBERSAM group)
2019 – 2021Associate lecturer Faculty of Medicine, Universitat Internacional de Catalunya (UIC)
2000 – 2004Founder and Head of the Psychiatry Department Hospital General de Granollers
1995 – 2010Consultant psychiatrist (acute and subacute inpatient units and research unit) Benito Menni CASM
Since 1996Psychiatry residency (MIR) tutor and lecturer on the CatSalut specialist training course (MIR, PIR, EIR)
Scientific societies
Member of the Sociedad Española de Psiquiatría y Salud Mental (SEPSM).
Member of the Societat Catalana de Psiquiatria i Salut Mental (SCPSM), where he has served on several boards.
Research and teaching
Researcher in the FIDMAG Hermanas Hospitalarias research group, part of CIBERSAM (Instituto de Salud Carlos III) and recognised as a research group by the Government of Catalonia (SGR, AGAUR). Member of the international ENIGMA neuroimaging consortium.
Principal investigator on competitive projects funded by ISCIII and La Marató de TV3 on first-episode psychosis, risk in the early stages of psychosis and deep brain stimulation in treatment-resistant schizophrenia.
Joint first author of one of the first randomised trials of deep brain stimulation in treatment-resistant schizophrenia (EBioMedicine, 2020).
Coordinates clinical trials of new treatments for depression and schizophrenia. Author of numerous articles in indexed international journals (see his PubMed and ORCID profiles).
Co-author of the Therapeutic Recommendations in Mental Disorders (RTM) and of the new clinical guideline on clozapine, presented at the Spanish National Congress of Psychiatry (Seville, 2026).
Individually recognised as a leading researcher by the Sociedad Española de Psiquiatría y Salud Mental (SEPSM) for meeting the criteria of its Research Excellence Programme.
Josep Trueta Prize for scientific research 2016 (Acadèmia de Ciències Mèdiques i de la Salut de Catalunya i de Balears) awarded to the research group led by Dr Edith Pomarol-Clotet.
Co-author of award-winning work recognised by the Catalan Society of Psychiatry and Mental Health: best publication and best presentation awards (2011–2024).
Best presentation awards at dual pathology conferences (Madrid 2019 and Seville 2020), as co-author.
